You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
天壇生物(600161.SH):所屬企業獲得藥品補充申請批准通知書並通過藥品GMP符合性檢查
格隆匯 04-10 16:37

格隆匯4月10日丨天壇生物(600161.SH)公佈,所屬成都蓉生藥業有限責任公司於近日收到國家藥品監督管理局簽發的《藥品補充申請批准通知書》,成都蓉生研製的“人纖維蛋白原”符合藥品註冊的相關要求。同時,成都蓉生相關生產場地已通過藥品GMP符合性檢查,並獲得了四川省藥品監督管理局簽發的《藥品GMP現場檢查結果通知書》。成都蓉生已獲得“人纖維蛋白原[規格:0.5g(25m1)/瓶]”的藥品補充申請批准通知書,並已通過GMP符合性檢查,可進行該產品的生產、上市和銷售。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account